Thorleifsdottir Ragna H, Sigurdardottir Sigrun L, Sigurgeirsson Bardur, Olafsson Jon H, Petersen Hannes, Sigurdsson Martin I, Gudjonsson Johann E, Johnston Andrew, Valdimarsson Helgi
Section of Dermatology, Faculty of Medicine, University of Iceland, Reykjavik, Iceland; Department of Immunology, Landspitali-National University Hospital of Iceland, Reykjavik, Iceland; Department of Dermatology, Akademiska University Hospital, Uppsala, Sweden.
Department of Immunology, Landspitali-National University Hospital of Iceland, Reykjavik, Iceland.
J Am Acad Dermatol. 2016 Nov;75(5):889-896. doi: 10.1016/j.jaad.2016.06.061. Epub 2016 Aug 9.
Carriage of the HLA-Cw*0602 allele is associated with a particular set of clinical features and treatment responses in psoriasis. Tonsillectomy can improve psoriasis.
We sought to evaluate whether HLA-Cw*0602 predicts a favorable outcome after tonsillectomy of patients with psoriasis.
This prospective case series followed up 28 tonsillectomized patients with plaque psoriasis for 24 months. The Psoriasis Area and Severity Index, Psoriasis Disability Index, and Psoriasis Life Stress Inventory were used for assessment. Tonsils were swabbed for bacteria and patients genotyped for HLA-Cw*0602.
After tonsillectomy, HLA-Cw0602 homozygotes showed significantly more improvement, compared with heterozygous and HLA-Cw0602-negative patients. Thus, Psoriasis Area and Severity Index score was reduced by 82% in the homozygous patients compared with 42% and 31%, respectively (P < .001), Psoriasis Disability Index score improved by 87% compared with 38% and 41%, respectively (P < .001), and Psoriasis Life Stress Inventory score was 82% reduced compared with 60% and 54%, respectively (P < .001). The homozygotes more often had psoriasis onset associated with a throat infection (P = .007) and an increased frequency of streptococcal throat infections per lifetime (P = .038).
Few patients were included and some data were retrospective.
Homozygous HLA-Cw*0602 carriage in plaque psoriasis may predict a favorable outcome after tonsillectomy.
HLA - Cw*0602等位基因的携带与银屑病的特定临床特征和治疗反应相关。扁桃体切除术可改善银屑病。
我们试图评估HLA - Cw*0602是否能预测银屑病患者扁桃体切除术后的良好预后。
该前瞻性病例系列对28例接受扁桃体切除术的斑块状银屑病患者进行了24个月的随访。使用银屑病面积和严重程度指数、银屑病残疾指数和银屑病生活压力量表进行评估。对扁桃体进行细菌拭子检查,并对患者进行HLA - Cw*0602基因分型。
扁桃体切除术后,与杂合子和HLA - Cw0602阴性患者相比,HLA - Cw0602纯合子患者改善更为显著。因此,纯合子患者的银屑病面积和严重程度指数评分降低了82%,而杂合子和阴性患者分别降低了42%和31%(P <.001);银屑病残疾指数评分分别改善了87%、38%和41%(P <.001);银屑病生活压力量表评分分别降低了82%、60%和54%(P <.001)。纯合子患者银屑病发病更常与咽喉感染相关(P =.007),且一生中链球菌性咽喉感染频率增加(P =.038)。
纳入患者较少,部分数据为回顾性。
斑块状银屑病患者携带纯合子HLA - Cw*0602可能预示扁桃体切除术后预后良好。